These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 15327647

  • 1. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
    Tomás I, Alvarez M, Limeres J, Otero JL, Saavedra E, López-Meléndez C, Diz P.
    Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
    [Abstract] [Full Text] [Related]

  • 2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 3. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W.
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.
    Diz Dios P, Tomás Carmona I, Limeres Posse J, Medina Henríquez J, Fernández Feijoo J, Alvarez Fernández M.
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2996-3002. PubMed ID: 16940094
    [Abstract] [Full Text] [Related]

  • 5. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman MA, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Controversies in antibiotic choices for odontogenic infections.
    Stefanopoulos PK, Kolokotronis AE.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):697-8. PubMed ID: 16731384
    [No Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes.
    Amábile-Cuevas CF, Hermida-Escobedo C, Vivar R.
    Clin Infect Dis; 2001 Mar 15; 32 Suppl 1():S30-2. PubMed ID: 11249826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
    Rodríguez-Avial I, Rodríguez-Avial C, Picazo JJ.
    Rev Esp Quimioter; 2001 Dec 15; 14(4):364-8. PubMed ID: 11856983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activity of the new quinolone WCK 771 against pneumococci.
    Appelbaum PC, Pankuch GA, Bozdogan B, Lin G, Jacobs MR, Patel MV, Gupte SV, Jafri MA, De Souza NJ, Khorakiwala HF.
    Clin Microbiol Infect; 2005 Jan 15; 11(1):9-14. PubMed ID: 15649298
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003.
    Johnson AP, Lamagni TL, Wale M, Cavendish S, Bishop L, Alhaddad N, Warner M, Livermore DM, Duckworth G, George RC.
    Int J Antimicrob Agents; 2005 Jun 15; 25(6):539-41. PubMed ID: 15890501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility testing of Streptococcus mitis group isolates.
    Bancescu G, Dumitriu S, Bancescu A, Defta C, Pana M, Ionescu D, Alecu S, Zamfirescu M.
    Indian J Med Res; 2004 May 15; 119 Suppl():257-61. PubMed ID: 15232207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
    Papaparaskevas J, Pantazatou A, Katsandri A, Houhoula DP, Legakis NJ, Tsakris A, Avlamis A.
    J Antimicrob Chemother; 2008 Jul 15; 62(1):137-41. PubMed ID: 18385145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.